Single Dose Study of MK-2060 in Healthy Japanese Participants
Phase 1
- Conditions
- Prevention of thrombotic vascular events
- Registration Number
- JPRN-jRCT2031220658
- Lead Sponsor
- Tanaka Yoshiyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Healthy male or female aged 18 to 50 years old with BMI 18 to 32 kg/m2
Exclusion Criteria
Has a history of clinically significant abnormalities or diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method